Ceftriaxone Sodium

头孢曲松钠

Report date: 2026/04/21 20:00:18
NME

Base Information

Drug NameCeftriaxone Sodium
Drug Alias Name头孢三嗪噻肟钠Ceftriaxona头孢三嗪钠Ceftriaxonum罗氏芬静脉注射剂 +[15] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics > Third-generation cephalosporins
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsLower Respiratory Tract InfectionsAcute bacterial skin and skin structure infectionsSchizophrenia +[28] 
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryBulgariaCanadaUnited States +[14] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEverest Medicines (China) Co LtdHasten Biopharma Co LtdChemix Inc +[9] 
Inactive CompaniesUniversity Of New EnglandCairo UniversityF. Hoffmann-La Roche Ag +[9] 
Active IndicationsIntellectual DisabilityBrain InjuriesSurgical Wound Infection +[7] 
Inactive IndicationsLower Respiratory Tract InfectionsAcute bacterial skin and skin structure infectionsSchizophrenia +[21] 

Other Information

ATC CodeJ01DD04
Related LinksWikipediaDrugBankKEGG